Spero Therapeutics (SPRO) Deferred Taxes (2016 - 2018)
Spero Therapeutics' (SPRO) quarterly Deferred Taxes came in at $645000.0 in Q4 2018, up 2054.55% YoY from $29936.7 in Q4 2017, and up 2115.62% on a QoQ basis from -$32000.0 in Q3 2018.
Spero Therapeutics (SPRO) Deferred Taxes (2016 - 2018) Analysis & Trends
Spero Therapeutics (SPRO) has 3 years of Deferred Taxes data on file, last reported at $645000.0 in Q4 2018.
- Quarterly Deferred Taxes rose 2054.55% year-over-year to $645000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $554000.0 (up 532.81% YoY) and the FY2018 annual result came in at $554000.0, up 532.81% from the prior year.
- Deferred Taxes grew to $645000.0 in Q4 2018, from -$32000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $645000.0 in Q4 2018 to a low of -$497000.0 in Q1 2017.
- A 3-year average of $44222.2 and a median of -$32000.0 in 2018 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 2054.55% in 2018, down 105.29% in 2018.
- Tracing SPRO's Deferred Taxes over 3 years: stood at -$28000.0 in 2016, then retreated by 17.86% to -$33000.0 in 2017, then jumped by 2054.55% to $645000.0 in 2018.
- The last three Deferred Taxes figures came in at $645000.0 (Q4 2018), -$32000.0 (Q3 2018), and -$23000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Spero Therapeutics | 71.30 Mn | 20.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 645,000.00 |
| Sep 30, 2018 | -32,000.00 |
| Jun 30, 2018 | -23,000.00 |
| Mar 31, 2018 | -36,000.00 |
| Dec 31, 2017 | -33,000.00 |
| Sep 30, 2017 | -33,000.00 |
| Jun 30, 2017 | 435,000.00 |
| Mar 31, 2017 | -497,000.00 |
| Dec 31, 2016 | -28,000.00 |